Related Experiment Video
Updated: Aug 24, 2026

Chronic Cranial Window Technique for Repeated Cortical Recordings During Anesthesia in Pigs
Published on: June 6, 2025
Current patterns of propofol use in PICU in the United Kingdom and North America
Stephen D Playfor1, K Venkatesh
1Paediatric Intensive Care Unit, Royal Manchester Children's Hospital, Pendlebury, Manchester, UK. stephen.playfor@ccmc.nhs.uk
Insights
Propofol is still used for sedation in many UK pediatric intensive care units (PICUs), despite safety guidance. North American PICUs report higher propofol use for sedation and procedures.
Area of Science:
- Pediatric Critical Care Medicine
- Pharmacology
- Anesthesiology
Background:
- Investigating current propofol utilization in pediatric intensive care units (PICUs) across the UK and North America.
- Assessing patterns of use for sedation and during procedures.
Purpose of the Study:
- To understand contemporary propofol prescribing practices in pediatric intensive care settings.
- To identify variations in propofol use between UK and North American PICUs.
Main Methods:
- Electronic questionnaire distributed to all UK PICUs and North American units offering PICU training fellowships.
- Response rates: 75% for UK units and 52% for North American units.
Main Results:
- 47% of UK PICUs and 61% of North American PICUs reported using propofol for ongoing sedation.
- Propofol was universally used for procedural sedation (100%), though UK units indicated a trend towards less frequent use.
- Usage was generally limited to specific clinical scenarios, lower doses, older children, and shorter durations.
Conclusions:
- Despite UK safety guidelines, propofol remains in use for ongoing sedation in nearly half of surveyed UK PICUs.
- The drug's utility and existing licensing for anesthesia maintenance in children over 3 contribute to its continued use, despite not being formally licensed for PICU sedation in similar contexts.
- Differences in reported use between UK and North American PICUs highlight varying clinical practices and potential guideline adherence.
Background:
Our aim was to investigate the current patterns of propofol use in pediatric intensive care units (PICUs) in the UK and North America.
Methods:
An electronic questionnaire was sent to all PICUs in the UK and those units offering PICU training fellowships in the USA and Canada.
Results:
We received responses from 15 UK units (75%) and 33 units in North America (52%). Of units who responded, 47% of UK units used propofol for ongoing sedation, compared with 61% of North American units. Units tended to use propofol in defined clinical circumstances, in limited doses, in older children and for relatively short periods. Propofol was used for sedation during procedures in 100% of units although 35% of UK units said that they would use it less frequently in this setting than in the past. Only 18% of North American Units reported that they would be less likely to use propofol for procedures than in the past.
Conclusions:
Despite clear guidance from the UK Committee on Safety of Medicines, propofol was still used for ongoing sedation in 47% of UK PICUs responding to our questionnaire. Reasons for this include the utility of the agent and its licensing for use in maintaining anesthesia in children over 3 years, but not for sedation in PICU in similar doses, for similar periods, in the same group of children.
Related Concept Videos
Parenteral Anesthetics: Overview
One-Compartment Open Model for IV Bolus Administration: General Considerations
The drug's presence in the body is defined by an equation representing the difference between the rates of drug entry and exit. Key parameters—elimination rate constant, half-life,...
Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance
A study on guinea pigs examined the...
General Anesthesia: Overview
General anesthesia induces unconsciousness in the whole body, while the others target specific areas or sensations. It is administered to minimize adverse effects, maintain...
Analysis of Population Pharmacokinetic Data
Dosage Regimens: Partial Pharmacokinetic Parameters
